GLUL and neoplasm: EV-Driven Metabolic Reprogramming: Emerging evidence suggests that CAF-EVs transfer lactate dehydrogenase A (LDHA) and glutamine synthetase to tumor cells, fostering an acidic, nutrient-depleted microenvironment that impairs T-cell glycolysis and cytotoxicity.